Politicians adept at spending tax revenue, but not so clever about the projects themselves...enormously wasteful expenditures:
From disused stadiums to deserted airports: Billion-dollar wastes of money
Printable View
Politicians adept at spending tax revenue, but not so clever about the projects themselves...enormously wasteful expenditures:
From disused stadiums to deserted airports: Billion-dollar wastes of money
We can add the Pentagon and MIC companies, and Big Pharma also.....Quote:
Originally Posted by tomcat
Big Pharma isn't in the public sector...
Well...if one looks deeper, it kinda is.Quote:
Originally Posted by tomcat
Government/Corporations are family.
Many haven't awaken from their dumbed-down slumber to recognize as such.
sorry, doesn't work...Big Pharma stocks are traded on stock exchanges...and their executives are beholden to stockholders...all the rest is paranoia...Quote:
Originally Posted by thaimeme
No, jeff.Quote:
Originally Posted by thaimemeWell...if one looks deeper, it kinda is.Quote:
Originally Posted by tomcat
Government/Corporations are family.
Many haven't awaken from their dumbed-down slumber to recognize as such.
I get your point...but, no.
right on...Quote:
Originally Posted by thaimeme
quote from: The smirking face of Big Pharma | SocialistWorker.orgQuote:
But what drug companies conveniently leave out is that they have little to no involvement in the front-end development of new chemical compounds. That work is done almost exclusively by universities and government research facilities, typically funded with taxpayer money.
In her book The Truth About Drug Companies, Marci Angell explains that, as a result of provisions in the Bayh-Doyle Act of 1980, publicly funded research facilities were allowed to claim ownership of their discoveries and license them to drug companies, which can then patent the new drug.
Only at this point do companies begin clinical trials with human subjects. Unlike the low success rate of drugs at the preclinical stage, one in five drugs that enter clinical trials will make it to market. Thus, explains Angell, "The great majority of drug candidates are... weeded out very early on, before a great deal of money has been invested in them."
And while clinical trials are expensive, the billions of dollars in profit that come from blockbuster drugs make the cost negligible. Thus, far from being the drivers of innovation, drug companies have managed to create a system in which taxpayers foot the bill for the most innovative part of the drug development process.
...a somber echo from farther back in the cave...or is that a Cummins B-Series warming up?...
^Either way Jeff made a valid point...
I told you I don't own a pickup truck.Quote:
Originally Posted by tomcat
:deadhorsebig: